Toshihiro Horii Selected Research

Lipocalin-2

11/2012

Lipocalin 2 bolsters innate and adaptive immune responses to blood-stage malaria infection by reinforcing host iron metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihiro Horii Research Topics

Disease

72	Malaria 02/2024 - 01/2002
26	Infections 12/2023 - 12/2006
6	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2023 - 02/2012
5	Parasitemia 01/2023 - 01/2007
5	Rupture 04/2020 - 04/2002
3	COVID-19 10/2021 - 08/2020
3	Communicable Diseases (Infectious Diseases) 05/2014 - 07/2010
2	Neoplasms (Cancer) 04/2024 - 01/2017
2	Pneumonia (Pneumonitis) 10/2021 - 12/2020
2	Filarial Elephantiasis (Lymphatic Filariasis) 01/2017 - 01/2017
2	Elephantiasis 01/2017 - 01/2017
2	Burkitt Lymphoma (Burkitt's Lymphoma) 08/2013 - 04/2012
2	Cerebral Malaria 03/2010 - 01/2007
1	Rabies (Hydrophobia) 02/2024
1	Fever (Fevers) 01/2022
1	Pneumothorax 12/2020
1	Iron Deficiencies 01/2020
1	Chronic Hepatitis C 12/2017
1	Filariasis 01/2017
1	Human Influenza (Influenza) 01/2016
1	Birth Weight (Birth Weights) 06/2013
1	Sepsis (Septicemia) 05/2013
1	Cholera 02/2013
1	Anemia 11/2012
1	Encephalitis (Encephalitis, Rasmussen) 12/2011
1	Bites and Stings (Sting) 12/2011

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 02/2024 - 12/2002
20	AntigensIBA 12/2023 - 12/2006
14	AntibodiesIBA 02/2024 - 02/2006
14	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2010
11	Antimalarials (Antimalarial Agents)IBA 01/2020 - 11/2003
9	Malaria VaccinesIBA 02/2024 - 04/2002
8	Immunoglobulin G (IgG)IBA 12/2017 - 02/2006
6	artemisinin (artemisinine)IBA 01/2023 - 01/2011
6	Merozoite Surface Protein 1 (MSA1)IBA 11/2016 - 11/2007
5	Serine (L-Serine)FDA Link 04/2021 - 12/2006
5	hemozoinIBA 06/2017 - 01/2005
4	Surface Antigens (Surface Antigen)IBA 01/2022 - 02/2010
4	Plasmodium serine repeat antigenIBA 04/2012 - 04/2002
4	Orotate PhosphoribosyltransferaseIBA 02/2012 - 04/2004
4	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2011 - 01/2007
3	Heme (Haem)IBA 01/2020 - 01/2005
3	EnzymesIBA 08/2013 - 02/2005
3	Carboxy-LyasesIBA 06/2006 - 06/2004
3	orotidylic acidIBA 06/2006 - 06/2004
3	pyrimidineIBA 02/2005 - 04/2004
2	Histidine (L-Histidine)FDA Link 12/2022 - 08/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022 - 06/2011
2	Chloroquine (Aralen)FDA LinkGeneric 02/2020 - 01/2019
2	IronIBA 01/2020 - 11/2012
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 06/2017 - 01/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 02/2013
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 11/2016 - 08/2014
2	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 01/2010
2	Hydroxyl RadicalIBA 01/2013 - 09/2010
2	AluminumIBA 01/2013 - 09/2010
2	Vaccine AdjuvantsIBA 12/2011 - 01/2010
2	Ferredoxins (Ferredoxin)IBA 12/2007 - 03/2007
2	Oxidoreductases (Dehydrogenase)IBA 12/2007 - 03/2007
2	EstersIBA 10/2004 - 11/2003
1	Saline SolutionIBA 04/2024
1	Nucleic AcidsIBA 12/2022
1	Oxygen (Dioxygen)IBA 10/2021
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 04/2021
1	ArtesunateIBA 01/2021
1	SteroidsIBA 12/2020
1	Indicators and Reagents (Reagents)IBA 08/2020
1	Blood Proteins (Serum Proteins)IBA 04/2020
1	Lumefantrine FDA Link 02/2020
1	allylpyrocatecholIBA 01/2020
1	Atovaquone (Mepron)FDA Link 01/2019
1	Pyrimethamine (Daraprim)FDA Link 01/2019
1	Mefloquine (Lariam)FDA LinkGeneric 01/2019
1	Leukocyte Immunoglobulin-like Receptor B1IBA 12/2017
1	Antimicrobial Cationic PeptidesIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2016
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2016
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 08/2013
1	Immunoglobulins (Immunoglobulin)IBA 08/2013
1	RibitolIBA 05/2013
1	16S Ribosomal RNAIBA 02/2013
1	Lipocalin-2IBA 11/2012
1	ToxoidsIBA 06/2012
1	Neutralizing AntibodiesIBA 06/2012
1	GibberellinsIBA 01/2012
1	InterferonsIBA 12/2011
1	Interferon Type IIBA 12/2011
1	Phosphotransferases (Kinase)IBA 12/2011

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2010
2	Mass Drug Administration 01/2017 - 01/2017
1	Punctures 04/2024
1	Aftercare (After-Treatment) 01/2023
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 12/2020
1	Extracorporeal Membrane Oxygenation 12/2020
1	Mechanical Ventilators (Ventilator) 12/2020
1	Insecticide-Treated Bednets 01/2020
1	Optical Devices 01/2020
1	Oral Administration 07/2019